544
Views
15
CrossRef citations to date
0
Altmetric
Liver and Biliary Disease

Paracetamol intoxications: a retrospective population-based study in Iceland

, , &
Pages 1344-1352 | Received 15 Apr 2012, Accepted 08 Jun 2012, Published online: 25 Jul 2012

References

  • Kaplowitz N. Acetaminophen hepatoxicity: What do we know, what don't we know, and what do we do next? Hepatology 2004;40:23–6.
  • Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 2005;42:1364–72.
  • Wei G, Kalaitzakis E, Bergquist A, Björnsson E. Long-term follow-up of patients with acute liver failure of indeterminate aetiology. Scand J Gastroenterol 2008;0843:984–91.
  • Craig DGN, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ. Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity. Br J Clin Pharmacol 2011;71:273–82.
  • Michna E, Duh MS, Korves C, Dahl JL. Removal of Opioid/Acetaminophen Combination Prescription Pain Medications: Assessing the Evidence for Hepatotoxicity and Consequences of Removal of These Medications. Pain Medicine 2010;11:369–78.
  • D Gunnell KH, Murray V, Garnier R, Bismuth C, Fagg J, Simkin S. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health 1997;51:175–9.
  • O'Rourke M, Garland MR, McCormick PA. Ease of access is a principal factor in the frequency of paracetamol overdose. Ir J Med Sci 2002;171:148.
  • Ott P DK, Hansen PB, Loft S, Poulsen HE. Consumption, overdose and death from analgesics during a period of over-the-counter availability of paracetamol in Denmark. J Intern Med 1990;227:423–8.
  • Prior MJ, Cooper K, Cummins P, Bowen D. Acetaminophen Availability Increases in Canada with No Increase in the Incidence of Reports of Inpatient Hospitalizations with Acetaminophen Overdose and Acute Liver Toxicity. Am J Ther 2004;11:443–52.
  • Haga C, Muan B, Cheung M, Lyngra M, Stromsaether CE, Lutro O, [Paracetamol poisonings after the lifting of the place of sale restriction]. Tidsskr Nor Laegeforen 2011;131:2115–18.
  • Manthripragada AD, Zhou EH, Budnitz DS, Lovegrove MC, Willy ME. Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States. Pharmacoepidemiology and Drug Safety 2011;20:819-26.
  • Kristinsson J, Palsson R, Gudjonsdottir GA, Blondal M, Gudmundsson S, Snook CP. Acute poisonings in Iceland: A prospective nationwide study. Clin Toxicol 2008;46:126–32.
  • Myers R, Li B, Fong A, Shaheen A, Quan V. Hospitalizations for acetaminophen overdose: a Canadian population-based study from 1995 to 2004. BMC Public Health 2007;7:143.
  • Myers RP, Li B, Shaheen AA. Emergency department visits for acetaminophen overdose: a Canadian population-based epidemiologic study (1997–2002). C J of Emerg Med 2007;9:267–74.
  • Myers RP, Shaheen AAM, Li B, Dean S, Quan H. Impact of Liver Disease, Alcohol Abuse, and Unintentional Ingestions on the Outcomes of Acetaminophen Overdose. Clin Gastroenterol Hepatol 2008;6:918–25.
  • Bond GR, Hite LK. Population-based Incidence and Outcome of Acetaminophen Poisoning by Type of Ingestion. Acad Emerg Med 1999;6:1115–20.
  • Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006;15:398–405.
  • WHO World Health Organization. International Classification of Diseases (ICD). Geneva: WHO. 2011. Available from http://www.who.int/classifications/icd/en/. [Cited 2010]
  • Statistics Iceland. Mid-year population by sex and age 1841-2010. Reykjavik: National Statistical Institute of Iceland. 2011. Available from http://www.hagstofa.is/Hagtolur/Mannfjoldi/Sveitarfelog. [Cited 2011 1. May]
  • Icelandic Medicines Agency (Lyfjastofnun). Ýmsar upplýsingar. Lyfjanotkun og velta. Reykjavik: Icelandic Medicines Agency. 2011. Available from http://www.lyfjastofnun.is/Tolfraedi/Lyfjanotkun_og_velta/2009/.
  • Craig DGN, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 2012;73:285–94.
  • Mímir Arnórsson L. Paracetamol 2004-2006. Reykjavík: Icelandic Medicines Agency; 2011.
  • Halldórsson M. Breyting á lyfseðilsskyldu verkjalyfja hefur gengið vel fyrir sig. Reykjavik: Landlaeknisembaettid - Directorate of Health. 2005. Available from http://www.landlaeknir.is/?PageID = 1055&NewsID = 1524. [Cited 2012 13. feb]
  • Icelandic Medicines Agency (Lyfjastofnun). Samantekt um lyfjabúðir á Íslandi og mönnun þeirra árið 2009. Reykjavik; 2010. Available from http://www.lyfjastofnun.is/Tolfraedi/Annad/.[ Cited 2011 24. august]
  • Bøe GH, Haga C, Andrew E, Berg KJ. Paracetamol forgiftninger i Norge 1990 - 2001. Tidsskr Nor Laegeforen 2004;12:1624–8.
  • Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997;337:1112–17.
  • Bergen H, Hawton K, Waters K, Cooper J, Kapur N. Epidemiology and trends in non-fatal self-harm in three centres in England: 2000-2007. Br J Psychiatry 2010;197:493–8.
  • Li C, Martin BC. Trends in emergency department visits attributable to acetaminophen overdoses in the United States: 1993–2007. Pharmacoepidemiol Drug Saf 2011;20:810–18.
  • Morgan O, Majeed A. Restricting paracetamol in the United Kingdom to reduce poisoning: a systematic review. J Public Health 2005;27:12–18.
  • Schmidt LE. Age and paracetamol self-poisoning. Gut 2005;54:686–90.
  • Budnitz DS, Lovegrove MC, Crosby AE. Emergency Department Visits for Overdoses of Acetaminophen-Containing Products. Am J Prev Med 2011;40:585–92.
  • Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in deliberate self-poisoning 1985-1997: trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol 2001;36:228–34.
  • Rumack BH. Acetaminophen misconceptions. Hepatology 2004;40:10–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.